Group I | Group II | Type-I | LRT | Qk > 0.95 | Critical amino acid sites | Type-II | Qk > 0.95 | Critical amino acid sites |
---|---|---|---|---|---|---|---|---|
θI ± s.e. | θII ± s.e. | |||||||
EXPA | EXPB | 0.498 ± 0.079 | 39.742 | 3 | 84C,145 V,172 L | -0.023 ± 0.259 | 15 | 62 T,65 L,103 F,104C,121P,122 M,141G, |
 |  |  |  |  |  |  |  | 143 V,160 F,176 V,177G,190*S,191R,207S |
EXPA | EXLB | 0.783 ± 0.082 | 91.136 | 17 | 45G,54Y,61 N,84C,102 N,104C, | 0.136 ± 0.278 | 53 | 18A,45G,54Y,56*Q,60 T,61 N,65 L,67 T,69 L, |
 |  |  |  |  | 161 T,165H,167Y,172*L,176 V, |  |  | 72 N,75S,76C,82I,102 N,104C,106P,107 N, |
 |  |  |  |  | 181D,184*G,185 V,191R,201 W, |  |  | 120P,125 F,126D,127 L,133*L,137Q,138Y, |
 |  |  |  |  | 202G |  |  | 145 V,147Y,154R,155R,160 F,162I,165H, |
 |  |  |  |  |  |  |  | 168 F,170 L,175 N,176 V,180G,181D,185 V, |
 |  |  |  |  |  |  |  | 187I,189G,191R,192*T,196*P,199R,201 W, |
 |  |  |  |  |  |  |  | 204 N,205 W,207S,208 N,209 N,210Y,213G |
EXPB | EXLB | 0.572 ± 0.141 | 14.448 | 0 | none | -0.081 ± 0.298 | 13 | 54Y,63A,67 T,103 F,106P,121P,125 F,126D, |
 |  |  |  |  |  |  |  | 134R,137R,140A,175 N |